Some therapeutic approaches may conflict with BPC-157 treatment
Isnt the statement .with no malice aforethought akin to saying I dont wish to be rude, but. Why make a point of such a statement when the irony is that the whole study is designed to cut down on perceived (and not scientifically backed up) excess treatment which served to harm patients and did not, by any stretch of the imagination prevent illness
Peptides: BPC-157 (Arginine salt), Larazotide (AT1001), KPV Tripeptide, GHK-Cu
Br J Pharmacol 119: 346350
A test to check the medication is free of foreign organisms and pathogens
BPC-157 is a recovery peptide with a genuinely interesting repair mechanism, but the result you get depends far less on the molecule and far more on the source, the dose, and the provider behind it